WebMar 22, 2024 · Overview. In accordance with the FDCAct, 21CFR50, and 21CFR312, the Food & Drug Administration (FDA) has authority over clinical investigations for drug and biological products regulated by the agency. 21CFR312 specifies that the scope of the FDA’s assessment for investigational new drug applications (INDs) includes all clinical … The National Medical Products Administration (NMPA, Chinese: 国家药品监督管理局, formerly the China Food and Drug Administration, or CFDA) was founded on the basis of the former State Food and Drug Administration (SFDA). In March 2013, the former regulatory body was rebranded and restructured as the China Food and Drug Administration, elevating it to a ministerial-level agency…
China Focusing Innovation Through ICH Global Regulatory …
WebFeb 2, 2024 · In recent years, China’s biosimilar drug industry has developed rapidly. By the end of 2024, China had the highest number of biosimilar drugs under research, with 391 biosimilar drugs in the R&D pipeline. As of 31/12/2024, 11 biosimilar drugs had been approved for marketing in China ( Table 1) ( Yeehong Business School, 2024 ). WebFeb 2, 2024 · In recent years, China’s biosimilar drug industry has developed rapidly. By the end of 2024, China had the highest number of biosimilar drugs under research, with … b\u0026b a minori
Obaidullah Ph.D, MPH - Director - Drug Regulatory …
WebJun 10, 2024 · FIGURE 1 China Regulatory Framework. Under this level there are regulations. One of the most often referred to is the Drug Registration Regulation (DRR), which was recently revised, and became … WebNov 8, 2024 · Registration requirements for medical devices in Vietnam are currently in a state of transition. New rules governing the registration of medical devices were … WebJan 7, 2024 · Drug Regulatory Authority: Medical Devices Regulatory Authority: Ministry of Health: Regional Affiliations: East Asia: China: National Medical Products Administration (NMPA) National Medical … b\u0026b a napoli centro